INTRODUCTION: Human herpesvirus 8 (HHV8) is necessary for Kaposi sarcoma (KS) to develop, but whether peripheral blood viral load is a marker of KS burden (total number of KS lesions), KS progression (the rate of eruption of new KS lesions), or both is unclear. We investigated these relationships in persons with AIDS. METHODS: Newly diagnosed patients with AIDS-related KS attending Mulago Hospital, in Kampala, Uganda, were assessed for KS burden and progression by questionnaire and medical examination. Venous blood samples were taken for HHV8 load measurements by PCR. Associations were examined with odds ratio (OR) and 95% confidence intervals (CI) from logistic regression models and with t-tests. RESULTS: Among 74 patients (59% men), median age was 34.5 years (interquartile range [IQR], 28.5-41). HHV8 DNA was detected in 93% and quantified in 77% patients. Median virus load was 3.8 logs10/10(6) peripheral blood cells (IQR 3.4-5.0) and was higher in men than women (4.4 vs. 3.8 logs; p=0.04), in patients with faster (>20 lesions per year) than slower rate of KS lesion eruption (4.5 vs. 3.6 logs; p<0.001), and higher, but not significantly, among patients with more (>median 20 KS lesions) than fewer KS lesions (4.4 vs. 4.0 logs; p=0.16). HHV8 load was unrelated to CD4 lymphocyte count (p=0.23). CONCLUSIONS: We show significant association of HHV8 load in peripheral blood with rate of eruption of KS lesions, but not with total lesion count. Our results suggest that viral load increases concurrently with development of new KS lesions.
INTRODUCTION:Human herpesvirus 8 (HHV8) is necessary for Kaposi sarcoma (KS) to develop, but whether peripheral blood viral load is a marker of KS burden (total number of KS lesions), KS progression (the rate of eruption of new KS lesions), or both is unclear. We investigated these relationships in persons with AIDS. METHODS: Newly diagnosed patients with AIDS-related KS attending Mulago Hospital, in Kampala, Uganda, were assessed for KS burden and progression by questionnaire and medical examination. Venous blood samples were taken for HHV8 load measurements by PCR. Associations were examined with odds ratio (OR) and 95% confidence intervals (CI) from logistic regression models and with t-tests. RESULTS: Among 74 patients (59% men), median age was 34.5 years (interquartile range [IQR], 28.5-41). HHV8 DNA was detected in 93% and quantified in 77% patients. Median virus load was 3.8 logs10/10(6) peripheral blood cells (IQR 3.4-5.0) and was higher in men than women (4.4 vs. 3.8 logs; p=0.04), in patients with faster (>20 lesions per year) than slower rate of KS lesion eruption (4.5 vs. 3.6 logs; p<0.001), and higher, but not significantly, among patients with more (>median 20 KS lesions) than fewer KS lesions (4.4 vs. 4.0 logs; p=0.16). HHV8 load was unrelated to CD4 lymphocyte count (p=0.23). CONCLUSIONS: We show significant association of HHV8 load in peripheral blood with rate of eruption of KS lesions, but not with total lesion count. Our results suggest that viral load increases concurrently with development of new KS lesions.
Authors: C Pellet; S Chevret; L Blum; C Gauvillé; M Hurault; G Blanchard; F Agbalika; C Lascoux; D Ponscarme; P Morel; F Calvo; C Lebbé Journal: J Invest Dermatol Date: 2001-10 Impact factor: 8.551
Authors: Sílvia de Sanjosé; Vickie Marshall; Judit Solà; Virgilio Palacio; Rosa Almirall; James J Goedert; F Xavier Bosch; Denise Whitby Journal: Int J Cancer Date: 2002-03-01 Impact factor: 7.396
Authors: D A Davis; A S Rinderknecht; J P Zoeteweij; Y Aoki; E L Read-Connole; G Tosato; A Blauvelt; R Yarchoan Journal: Blood Date: 2001-05-15 Impact factor: 22.113
Authors: Michael J Cannon; Sheila C Dollard; Jodi B Black; Brian R Edlin; Connie Hannah; Susan E Hogan; Mitesh M Patel; Harold W Jaffe; Margaret K Offermann; Thomas J Spira; Philip E Pellett; Clifford J Gunthel Journal: AIDS Date: 2003-01-24 Impact factor: 4.177
Authors: D Whitby; M R Howard; M Tenant-Flowers; N S Brink; A Copas; C Boshoff; T Hatzioannou; F E Suggett; D M Aldam; A S Denton Journal: Lancet Date: 1995-09-23 Impact factor: 79.321
Authors: Fatma M Shebl; Benjamin Emmanuel; Lisa Bunts; Benon Biryahwaho; Christine Kiruthu; Meei-Li Huang; Ruth M Pfeiffer; Corey Casper; Sam M Mbulaiteye Journal: J Med Virol Date: 2013-09 Impact factor: 2.327
Authors: Lan Lin; Jeannette Y Lee; Lawrence D Kaplan; Bruce J Dezube; Ariela Noy; Susan E Krown; Alexandra M Levine; Yanxing Yu; Gary S Hayward; Richard F Ambinder Journal: J Clin Oncol Date: 2009-04-06 Impact factor: 44.544
Authors: E Long; M Ilie; V Hofman; K Havet; E Selva; C Butori; J P Lacour; A M Nelson; G Cathomas; P Hofman Journal: Virchows Arch Date: 2009-05-30 Impact factor: 4.064
Authors: Anna E Coghill; Jeannette M Schenk; Zeina Mahkoul; Jackson Orem; Warren Phipps; Corey Casper Journal: AIDS Date: 2018-02-20 Impact factor: 4.177
Authors: Christopher De Boer; Nixon Niyonzima; Jackson Orem; John Bartlett; S Yousuf Zafar Journal: Infect Agent Cancer Date: 2014-05-20 Impact factor: 2.965
Authors: Christine Johnston; Jackson Orem; Fred Okuku; Mary Kalinaki; Misty Saracino; Edward Katongole-Mbidde; Merle Sande; Allan Ronald; Keith McAdam; Meei-Li Huang; Linda Drolette; Stacy Selke; Anna Wald; Lawrence Corey; Corey Casper Journal: PLoS One Date: 2009-01-20 Impact factor: 3.240